Physician profile
Bruce Potts
NPI 1598794281
$1,272.16
in general payments reported to CMS, 2019-2025
10 companies · $240 in 2025
The $240 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $328 · 2020: $25.07 · 2021: $123 · 2022: $255 · 2023: $115 · 2024: $186 · 2025: $240.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $484 · Entertainment: $56.69.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $484.08 |
| Entertainment | $56.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $263.53 | 2020-2024 | Myday Contact Lens |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $257.29 | 2019 | |
| Abbvie INC. | $145.47 | 2022 | |
| Lkc Technologies, INC. | $125.83 | 2025 | |
| Carl Zeiss Meditec USA, INC. | $122.59 | 2021 | |
| Tarsus Pharmaceuticals, INC. | $99.23 | 2025 | Xdemvy |
| Bausch & Lomb Americas INC. | $71.86 | 2022-2025 | Xiidra, Miebo |
| Carl Zeiss Meditec, INC. | $71.12 | 2019 | |
| Alcon Vision LLC | $58.55 | 2023 | Precision 1 |
| Optos, INC. | $56.69 | 2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Potts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.